Study guide
5.10 Scope of Practice, Clinical Supervision & Conflict of Interest
Certified Genetic Counselor CGC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the CGC Exam & Credential 1.2 Eligibility Categories, Application & Fees 1.3 Scoring, Pass Rate & Test-Day Logistics
2 Domain 1A: Clinical Information
1.4 Medical & Pregnancy History 1.5 Teratogens, Exposures & Non-Genetic Risk Factors 1.6 Differential Diagnosis, Indication & Referral Urgency 1.7 Referral Triage, Case Preparation & Records Review
3 Domain 1B: Human Development
1.8 Fetal Development 1.9 Developmental Milestones 1.10 Physical & Psychological Development
4 Domain 1C: Chromosomal & Contiguous Gene Syndromes
1.11 Aneuploidy Syndromes (Down, Turner, Klinefelter, Edwards, Patau) 1.12 Microdeletion Syndromes (22q11.2, Williams, and Related) 1.13 Imprinting Disorders (PWS, Angelman, Beckwith-Wiedemann, Russell-Silver)
5 Domain 1C: Hereditary Cancer Syndromes
1.14 Hereditary Breast & Ovarian Cancer (BRCA1/2, PALB2, and Related) 1.15 Lynch Syndrome & Polyposis Syndromes 1.16 Li-Fraumeni, VHL, MEN, NF1/NF2 & Other Cancer Predisposition
6 Domain 1C: Metabolic, Neuromuscular & Multisystem Conditions
1.17 Inborn Errors of Metabolism & Storage Disorders 1.18 Neuromuscular Disease & Fragile X Spectrum 1.19 Connective Tissue & Cardiovascular Genetics 1.20 Screening, Surveillance, Treatment & Diagnostic Strategy Framework
7 Domain 2A: Pedigree & Risk Assessment
2.1 Family History, Pedigree Construction & Analysis 2.2 Mendelian Risk Calculations 2.3 Bayesian Risk Calculations 2.4 Empiric Risk, Multifactorial Recurrence & Risk-Assessment Models 2.5 Residual Risk & Follow-Up Medical Plans
8 Domain 2B: Inheritance Principles
2.6 Mendelian Inheritance Patterns 2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial) 2.8 Penetrance, Expressivity, Anticipation & Heterogeneity 2.9 Mosaicism, X-Inactivation & Epigenetic Modifiers of Phenotype
9 Domain 2B: Population Genetics & Variation
2.10 Population Genetics, HWE & Quantitative Genetics 2.11 Human Genetic Variation & Disease Susceptibility
10 Domain 3A: Test Methodologies
3.1 Karyotype, FISH & Chromosomal Microarray 3.2 Molecular Diagnostics (Sanger, NGS Panels, WES, WGS, MLPA) 3.3 Sample Types, Clinical Context & Predictive Metrics
11 Domain 3A: Variant Interpretation
3.4 ACMG/AMP Variant Classification 3.5 Reanalysis, Reclassification & Validity/Utility Framework
12 Domain 3B: Testing Options
3.6 Diagnostic Testing Strategies 3.7 Screening Testing (including Newborn Screening) 3.8 Predictive & Pre-symptomatic Testing 3.9 Carrier, Somatic & Research Testing
13 Domain 3C: Reproductive Risk Management
3.10 Assisted Reproductive Technologies & PGT 3.11 Family Planning & Reproductive Options 3.12 Prenatal Screening (NIPT, Serum Markers) 3.13 Prenatal Diagnostic Procedures (CVS, Amniocentesis)
14 Domain 4A: Counseling Foundations
4.1 Contracting & Interviewing Techniques 4.2 Psychosocial Assessment, Follow-Up & Family Dynamics 4.3 Client Personal Identity & Cultural Humility
15 Domain 4A: Theories, Coping & Dynamics
4.4 Counseling Theories & Models (REM, Trajectory) 4.5 Defense Mechanisms, Coping & Decision-Making Styles 4.6 Grief, Perinatal Loss & Crisis Response 4.7 Self-Awareness & Client-Counselor Dynamics
16 Domain 4B: Communication & Education
4.8 Delivery Modes & Working with Interpreters 4.9 Risk Communication Theories & Models 4.10 Results Delivery & Long-Term Follow-Up 4.11 Health Literacy, Informed Consent & Informed Decision Making
17 Domain 5A–B: Finance & Client Resources
5.1 Insurance Policies, Billing & Letters of Medical Necessity 5.2 Billing, Coding & Reimbursement Compliance 5.3 Client Resources, Appropriateness & Timely Delivery
18 Domain 5C: Legal & Regulatory Requirements
5.4 GINA & Genetic Non-Discrimination Legislation 5.5 Privacy, Confidentiality, Documentation & Genomic Data Security 5.6 Human-Subjects Research Standards & Patient Access to Information 5.7 CLIA, Laboratory-Developed Tests & FDA Oversight 5.8 Genomic Data Security, DTC Testing & Data Sharing
19 Domain 5D: Professional Frameworks
5.9 NSGC Code of Ethics & Ethical Decision Making 5.10 Scope of Practice, Clinical Supervision & Conflict of Interest 5.11 Licensure, Credentialing & Maintaining the CGC Credential 5.12 Evidence-Based Practice & Professional/Public Education
20 Integration & Exam Strategy
6.1 Integrating Domains in Case-Based Practice & Exam Strategy
5.10 Scope of Practice, Clinical Supervision & Conflict of Interest
Key Takeaways Explain This Topic AI
Genetic counselors practice within defined scope—risk assessment, education, counseling, test facilitation/interpretation in the counseling role—while diagnosis, prescribing, and clinical lab directorship remain distinct professional roles.
Clinical supervision of students requires progressive responsibility, patient-safety primacy, honest evaluation, dual-role awareness, and clear feedback—not silent “sink or swim.”
Conflicts of interest arise from lab relationships, industry speaking, gifts, research funding, and self-referral patterns; identify, disclose, manage, or recuse.
Exam stems often ask who should perform a task (GC vs physician vs lab director) or which COI management step is appropriate.
Scope creep and undisclosed industry ties undermine informed consent and professional trust—even when intentions are educational.
Last updated: August 2026
Scope of practice: what genetic counselors do—and do not do
Scope of practice defines activities a genetic counselor is educated, trained, and (where applicable) licensed/credentialed to perform. Exact statutes vary by jurisdiction, but board items test role clarity more than memorizing one state’s statute text.
Genetic counselors typically:
Elicit medical and family histories and construct pedigrees.
Perform risk assessment and differential generation within genetics expertise.
Provide education and counseling to support informed decision making.
Facilitate appropriate genetic testing and coordinate results disclosure.
Interpret results in the counseling context (what the report means for this client/family; psychosocial implications; cascade plan).
Document, advocate for access, and refer for medical management.
Genetic counselors typically do not :
Practice medicine as physicians (independent medical diagnosis/treatment plans outside collaborative models).
Serve as the clinical laboratory director who assumes CLIA responsibility for assay validation and report sign-out (unless separately qualified and appointed).
Prescribe medications or order invasive procedures outside collaborative/authorized protocols.
Provide legal advice, guarantee insurance outcomes, or act as the client’s attorney.
Role Core accountability Overlap with GC Exam trap
Genetic counselor Counseling, risk assessment, education, test navigation Case coordination “GC should independently sign out a novel assay as lab director”
Physician / APP Medical diagnosis, management orders, procedures Shared clinics; GC recommendations inform care “GC alone clears for risk-reducing surgery without surgical consult”
Lab director / pathologist / molecular geneticist Analytic validity, report authorization under lab regs GCs may draft counseling notes; labs issue formal results “GC overrides a signed lab classification without lab process”
Student / supervisee Learning under supervision Graduated tasks “Let student disclose alone on first day without oversight plan”
Collaborative practice without scope blur
In many settings GCs practice under institutional protocols with physician collaborators. Collaboration is not a license to exceed competence. If a client needs chemotherapy selection, surgical timing, or psychiatric crisis intervention beyond GC skill, the ethical/scope-correct move is referral and handoff , not improvisation.
When results are ambiguous (VUS, mosaic findings, conflicting reports), the GC explains counseling implications and uncertainty; reclassification or lab-method questions route through laboratory channels and appropriate clinicians—not informal Facebook re-interpretation presented as final truth.
Clinical supervision of students
Supervising genetic counseling students is an explicit Domain 5D topic. Supervision is a professional responsibility , not optional mentoring fluff.
Core duties:
Patient safety first — Supervisee autonomy never outruns competence for the task (consent, disclosure of pathogenic results, crisis counseling).
Progressive responsibility — Match tasks to demonstrated skill; increase independence with observation → co-counsel → observed independence.
Informed clients — Clients know a student is involved and may decline student participation without penalty to care.
Honest evaluation — Feedback is timely, specific, and documented; passing a student who is unsafe harms future clients and the profession.
Dual roles managed — Supervisor is educator and gatekeeper; avoid exploitative dual relationships; seek co-supervision if conflicted.
Confidentiality of student performance — Share evaluation through proper program channels, not hallway gossip.
Modeling ethics — Students learn COI disclosure, documentation honesty, and respectful communication by watching supervisors.
Supervision situation Appropriate action Inappropriate action
Student’s first pathogenic cancer disclosure Co-counsel or direct observation with debrief Send student alone “for experience”
Student repeatedly misses critical pedigree questions Structured remediation plan + closer oversight Ignore until final evaluation fails them abruptly
Client refuses student Honor refusal; teach student professionalism Pressure client to “help the student learn”
Student distressed after session Support + referral resources; separate evaluation fairness Mock student or skip processing
- Supervisor is also the student’s therapist friend Recuse/transfer supervisory role Continue without disclosure
- Feedback that boards reward
Effective feedback is behavior-specific (“You interrupted before the client finished describing the miscarriage history”) tied to competencies, with a plan for the next session. Vague praise or silent tolerance of unsafe practice both fail supervision standards.
Conflict of interest (COI): identify and manage
A conflict of interest exists when personal, financial, or professional interests could compromise—or appear to compromise—professional judgment. In genetics, high-yield COI sources include:
Laboratory relationships — employment, consulting, advisory boards, volume-based incentives, preferred-lab contracts that steer orders.
Industry speaking / honoraria — sponsored talks that function as marketing.
Gifts and hospitality — meals, travel, devices that create reciprocal obligation.
Research funding / equity — ownership in a testing company or sponsored trial enrollment pressure.
Self-referral patterns — routing clients to an entity that financially benefits the counselor/clinic without disclosure of alternatives.
Dual relationships — social, financial, or supervisory overlaps with clients or students.
Management hierarchy
Identify — Ask: Could a reasonable client question my objectivity?
Disclose — Tell the client (and institution) about relevant relationships in plain language.
Manage — Offer clinically equivalent alternatives; use institutional preferred pathways transparently; separate education from sales.
Recuse — Transfer care or speaking role when conflict cannot be adequately managed.
Document — Record disclosure and client choice.
COI pattern Red flag Better management
Lab advisory board + exclusive ordering No alternatives discussed Disclose role; present clinically appropriate lab options and rationale
Industry-sponsored “education” dinner Slides are product pitches only Label sponsorship; balance with independent guidelines
Self-referral to counselor-owned testing LLC Hidden ownership Disclose ownership; offer outside options; follow institutional policy
Student grades tied to lab that pays supervisor Biased evaluation risk Separate evaluation authority; transparency to program
Appearance matters
Even without proven bias, undisclosed financial ties can undermine informed consent. Exam answers that say “no need to mention the consulting fee because the test is still good” are usually wrong. Disclosure supports autonomy; nondisclosure supports neither veracity nor fidelity.
Integrated scenarios
Scenario A — scope: Client asks the GC to “clear” them for bilateral mastectomy based on a VUS. Best action: clarify that surgical decisions require appropriate surgical/medical specialists; GC provides risk education and uncertainty counseling—not surgical clearance.
Scenario B — supervision: Mid-session, a student freezes during results disclosure. Supervisor should step in to protect the client, then debrief and remediate—not leave the client hanging to “teach resilience.”
Scenario C — COI: GC receives honoraria from Lab Z and routinely orders Lab Z without mentioning alternatives when peers are equivalent. Best practice: disclose relationship, discuss options/criteria, document; consider recusal from ordering decisions if bias cannot be managed.
Scenario D — self-referral: Clinic policy funnels all panels to an affiliated lab with ownership interest. Ethical practice requires transparency about affiliation and, when clinically relevant, discussion of outside options/limitations—not pretending no alternatives exist.
Common traps
Confusing counseling interpretation with formal laboratory sign-out authority.
Treating student supervision as optional observation without accountability.
Passing unsafe students to avoid conflict.
Hiding industry ties because “everyone does it.”
Steering testing solely for financial gain or convenience without clinical rationale.
Practicing medicine or psychotherapy beyond competence instead of referring.
Quick exam checklist
Is this task within GC scope, or does it need physician/lab/other referral?
If a student is involved, is safety, consent, and supervision intensity appropriate?
Is there a financial or dual-relationship COI—and has it been disclosed/managed?
Would a reasonable client still trust the recommendation after full disclosure?
Is evaluation/feedback honest and documented?